Ownership history in MPM BioImpact LLC · 14 quarters on record
This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Madrigal Pharmaceuticals inc (MDGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 96,780 | -3,635 | -3.6% | 6.45% | $56.4M | $582.34 |
| 2025 Q3 | UNCHANGED | 100,415 | — | 0% | 7.54% | $46.1M | $458.66 |
| 2025 Q2 | UNCHANGED | 100,415 | — | 0% | 5.27% | $30.4M | $302.64 |
| 2025 Q1 | ADDED | 100,415 | +28,020 | +38.7% | 5.72% | $33.3M | $331.23 |
| 2024 Q3 | ADDED | 72,395 | +1,210 | +1.7% | 2.30% | $15.4M | $212.22 |
| 2024 Q2 | ADDED | 71,185 | +9,786 | +15.9% | 3.10% | $19.9M | $280.16 |
| 2024 Q1 | ADDED | 61,399 | +20,489 | +50.1% | 2.64% | $16.4M | $267.04 |
| 2023 Q4 | ADDED | 40,910 | +51 | +0.1% | 2.21% | $9.5M | $231.38 |
| 2023 Q3 | ADDED | 40,859 | +2,848 | +7.5% | 1.59% | $6.0M | $146.04 |
| 2023 Q2 | ADDED | 38,011 | +1,973 | +5.5% | 1.77% | $8.8M | $231.00 |
As of 2025 Q4 — sorted by position size